Cargando…
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan
BACKGROUND: It was reported that eribulin regulates the tumor microenvironment, including the immune system, by inducing vascular remodeling. Lymphocyte counts are a critical index of immune response in patients. The non-Asian, global EMBRACE study has suggested that baseline absolute lymphocyte cou...
Autores principales: | Takahashi, Masato, Inoue, Kenichi, Mukai, Hirofumi, Yamanaka, Takashi, Egawa, Chiyomi, Miyoshi, Yasuo, Sakata, Yukinori, Muramoto, Kenzo, Ikezawa, Hiroki, Matsuoka, Toshiyuki, Tsurutani, Junji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213560/ https://www.ncbi.nlm.nih.gov/pubmed/33677779 http://dx.doi.org/10.1007/s12282-021-01232-1 |
Ejemplares similares
-
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting
por: Inoue, Kenichi, et al.
Publicado: (2020) -
Chemotherapy-induced peripheral neuropathy in breast cancer patients treated with eribulin: interim data from a post-marketing observational study
por: Tsurutani, Junji, et al.
Publicado: (2018) -
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study
por: Miyoshi, Yasuo, et al.
Publicado: (2020) -
Safety of Gliadel Implant for Malignant Glioma: Report of Postmarketing Surveillance in Japan
por: NISHIKAWA, Ryo, et al.
Publicado: (2021) -
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
por: Watanabe, Junichiro, et al.
Publicado: (2017)